Related Experiment Videos

Simultaneous progressive multifocal leukoencephalopathy, Epstein-Barr virus (EBV) latent infection and cerebral

D Farge1, R Hervé, J Mikol

  • 1Department of Internal Medicine, Saint Louis Hospital, Paris VII University, France.

Leukemia
|February 1, 1994
PubMed

Insights

In an immunocompromised patient without HIV, concurrent progressive multifocal leukoencephalopathy (PML) and B chronic lymphocytic leukemia (CLL) brain infiltration occurred. This case highlights EBV-associated B-cell transformation potentially facilitating JC virus reactivation and co-infection.

Area of Science:

  • Neurovirology
  • Hematology
  • Immunology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease caused by the JC virus (JCV).
  • Chronic lymphocytic leukemia (CLL) is a B-cell malignancy often associated with immunosuppression.
  • Cerebral co-infections with multiple viruses can complicate diagnosis and treatment in immunocompromised individuals.

Observation:

  • A non-HIV patient presented with neurological symptoms and imaging findings suggestive of white matter lesions.
  • Computerized tomography (CT) revealed subcortical hypodensities, while magnetic resonance imaging (MRI) showed extensive T2-weighted signal hyperintensities.
  • JC virus (JCV) DNA was detected in peripheral blood and cerebrospinal fluid (CSF).

Findings:

  • Stereotactic brain biopsy confirmed PML, with leukemic B cells infiltrating demyelinated areas.
  • In situ hybridization (ISH) identified both JCV and Epstein-Barr virus (EBV) within the cerebral lesions.
  • Leukemic B cells expressed latent membrane protein and EBV, along with CD23 adhesion molecules.

Implications:

  • Epstein-Barr virus (EBV)-transformed B lymphocytes may promote JC virus (JCV) entry or reactivation in the brain.
  • This case demonstrates simultaneous PML and cerebral CLL infiltration in an immunosuppressed patient.
  • Understanding viral co-pathogenesis is crucial for managing complex neurological complications in hematological malignancies.

Related Concept Videos